semaglutide heart benefits of GLP-1 Evaluating the Cardiovascular Benefits of

Food and Drug Administration approved the semaglutide injection (2.4 mg once weekly) for chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol), for use in addition to a reduced calorie diet and increased physical activity

Were here with the tools, support, and medical expertise to help you lose weight and live better

For some, it starts on day one, with a subtle sense of fullness that makes large meals less appealing

Number of gastrointestinal cancer events per arm, HRs, Confidence Intervalsor Cis

But on May 7, 2025, a US District Court in the Northern District of Texas upheld the FDA decision